|
2024-09-17 |
2024-09-13 |
V
Verkauf
|
Elsbree David B
Nicht geschäftsführender Verwaltungsratsmitglied
|
55
-70.5%
2,42
133 USD
|
55
-70.5%
|
2,42
|
133 USD
|
|
|
2023-09-29 |
2023-09-28 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
1.937.852
-100.0%
0,16
305.212 USD
|
1.937.852
-100.0%
|
0,16
|
305.212 USD
|
|
|
2023-09-29 |
2023-09-28 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
571.796
-100.0%
0,16
90.058 USD
|
571.796
-100.0%
|
0,16
|
90.058 USD
|
|
|
2023-09-29 |
2023-09-28 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
1.780.317
-100.0%
0,16
280.400 USD
|
1.780.317
-100.0%
|
0,16
|
280.400 USD
|
|
|
2023-09-29 |
2023-09-28 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
2.858.980
-100.0%
0,16
450.289 USD
|
2.858.980
-100.0%
|
0,16
|
450.289 USD
|
|
|
2023-09-29 |
2023-09-27 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
1.621.313
-45.6%
0,19
310.644 USD
|
1.621.313
-45.6%
|
0,19
|
310.644 USD
|
|
|
2023-09-29 |
2023-09-27 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
478.396
-45.6%
0,19
91.661 USD
|
478.396
-45.6%
|
0,19
|
91.661 USD
|
|
|
2023-09-29 |
2023-09-27 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
1.489.512
-45.6%
0,19
285.390 USD
|
1.489.512
-45.6%
|
0,19
|
285.390 USD
|
|
|
2023-09-29 |
2023-09-27 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
2.391.981
-45.6%
0,19
458.304 USD
|
2.391.981
-45.6%
|
0,19
|
458.304 USD
|
|
|
2023-09-28 |
2023-09-26 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
1.461.849
-29.1%
0,20
293.393 USD
|
1.461.849
-29.1%
|
0,20
|
293.393 USD
|
|
|
2023-09-28 |
2023-09-26 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
431.343
-29.1%
0,20
86.571 USD
|
431.343
-29.1%
|
0,20
|
86.571 USD
|
|
|
2023-09-28 |
2023-09-26 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
1.343.011
-29.1%
0,20
269.542 USD
|
1.343.011
-29.1%
|
0,20
|
269.542 USD
|
|
|
2023-09-28 |
2023-09-26 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
2.156.717
-29.1%
0,20
432.853 USD
|
2.156.717
-29.1%
|
0,20
|
432.853 USD
|
|
|
2023-09-27 |
2023-09-25 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
67.767
-1.3%
0,25
16.942 USD
|
67.767
-1.3%
|
0,25
|
16.942 USD
|
|
|
2023-09-27 |
2023-09-25 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
19.996
-1.3%
0,25
4.999 USD
|
19.996
-1.3%
|
0,25
|
4.999 USD
|
|
|
2023-09-27 |
2023-09-25 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
62.258
-1.3%
0,25
15.565 USD
|
62.258
-1.3%
|
0,25
|
15.565 USD
|
|
|
2023-09-27 |
2023-09-25 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
99.979
-1.3%
0,25
24.995 USD
|
99.979
-1.3%
|
0,25
|
24.995 USD
|
|
|
2023-09-26 |
2023-09-22 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
1.376.848
-21.3%
0,26
356.328 USD
|
1.376.848
-21.3%
|
0,26
|
356.328 USD
|
|
|
2023-09-26 |
2023-09-22 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
406.263
-21.3%
0,26
105.141 USD
|
406.263
-21.3%
|
0,26
|
105.141 USD
|
|
|
2023-09-26 |
2023-09-22 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
1.264.920
-21.3%
0,26
327.361 USD
|
1.264.920
-21.3%
|
0,26
|
327.361 USD
|
|
|
2023-09-26 |
2023-09-22 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
2.031.313
-21.3%
0,26
525.704 USD
|
2.031.313
-21.3%
|
0,26
|
525.704 USD
|
|
|
2023-09-25 |
2023-09-21 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
1.718.087
-21.0%
0,30
516.285 USD
|
1.718.087
-21.0%
|
0,30
|
516.285 USD
|
|
|
2023-09-25 |
2023-09-21 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
506.951
-21.0%
0,30
152.339 USD
|
506.951
-21.0%
|
0,30
|
152.339 USD
|
|
|
2023-09-25 |
2023-09-21 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
1.578.419
-21.0%
0,30
474.315 USD
|
1.578.419
-21.0%
|
0,30
|
474.315 USD
|
|
|
2023-09-25 |
2023-09-21 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
2.534.754
-21.0%
0,30
761.694 USD
|
2.534.754
-21.0%
|
0,30
|
761.694 USD
|
|
|
2023-09-22 |
2023-09-20 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
2.101.784
-20.4%
0,31
652.814 USD
|
2.101.784
-20.4%
|
0,31
|
652.814 USD
|
|
|
2023-09-22 |
2023-09-20 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
620.167
-20.4%
0,31
192.624 USD
|
620.167
-20.4%
|
0,31
|
192.624 USD
|
|
|
2023-09-22 |
2023-09-20 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
1.930.923
-20.4%
0,31
599.745 USD
|
1.930.923
-20.4%
|
0,31
|
599.745 USD
|
|
|
2023-09-22 |
2023-09-20 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
3.100.836
-20.4%
0,31
963.120 USD
|
3.100.836
-20.4%
|
0,31
|
963.120 USD
|
|
|
2023-09-21 |
2023-09-19 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
2.819.506
-21.5%
0,37
1.031.939 USD
|
2.819.506
-21.5%
|
0,37
|
1.031.939 USD
|
|
|
2023-09-21 |
2023-09-19 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
831.943
-21.5%
0,37
304.491 USD
|
831.943
-21.5%
|
0,37
|
304.491 USD
|
|
|
2023-09-21 |
2023-09-19 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
2.590.300
-21.5%
0,37
948.050 USD
|
2.590.300
-21.5%
|
0,37
|
948.050 USD
|
|
|
2023-09-21 |
2023-09-19 |
V
Verkauf
|
CR Group L.P.
Large shareholder
|
4.159.717
-21.5%
0,37
1.522.456 USD
|
4.159.717
-21.5%
|
0,37
|
1.522.456 USD
|
|
|
2023-04-06 |
2023-03-28 |
GV
Geplanter Verkauf
|
Gibbs Michael Terrence
General Counsel
Führungsperson
|
239
-3.5%
0,48
115 USD
|
239
-3.5%
|
0,48
|
115 USD
|
|
|
2023-03-09 |
2023-02-28 |
GV
Geplanter Verkauf
|
Gibbs Michael Terrence
General Counsel
Führungsperson
|
1.585
-19.6%
0,59
935 USD
|
1.585
-19.6%
|
0,59
|
935 USD
|
|
|
2023-03-09 |
2023-02-28 |
GV
Geplanter Verkauf
|
Sperzel John J III
Chairman and CEO
Geschäftsführender Verwaltungsratsmitglied
|
2.898
-14.3%
0,59
1.710 USD
|
2.898
-14.3%
|
0,59
|
1.710 USD
|
|
|
2023-03-09 |
2023-02-28 |
GV
Geplanter Verkauf
|
Sprague John M
Chief Financial Officer
Führungsperson
|
1.148
-13.6%
0,59
677 USD
|
1.148
-13.6%
|
0,59
|
677 USD
|
|
|
2023-03-09 |
2023-02-22 |
GV
Geplanter Verkauf
|
Gibbs Michael Terrence
General Counsel
Führungsperson
|
2.145
-29.3%
0,65
1.394 USD
|
2.145
-29.3%
|
0,65
|
1.394 USD
|
|
|
2023-03-09 |
2023-02-22 |
GV
Geplanter Verkauf
|
Sperzel John J III
Chairman and CEO
Geschäftsführender Verwaltungsratsmitglied
|
6.875
-33.6%
0,65
4.469 USD
|
6.875
-33.6%
|
0,65
|
4.469 USD
|
|
|
2023-03-09 |
2023-02-22 |
GV
Geplanter Verkauf
|
Giffin Brett A.
Chief Commercial Officer
Führungsperson
|
537
-39.0%
0,65
349 USD
|
537
-39.0%
|
0,65
|
349 USD
|
|
|
2023-03-09 |
2023-02-22 |
GV
Geplanter Verkauf
|
Sprague John M
Chief Financial Officer
Führungsperson
|
1.545
-21.9%
0,65
1.004 USD
|
1.545
-21.9%
|
0,65
|
1.004 USD
|
|
|
2022-11-22 |
2022-11-10 |
V
Verkauf
|
Giffin Brett A.
Chief Commercial Officer
Führungsperson
|
1.292
-36.4%
1,79
2.317 USD
|
1.292
-36.4%
|
1,79
|
2.317 USD
|
|
|
2022-04-11 |
2022-04-08 |
K
Kauf
|
Barclay Alec
Chief Operations Officer
Führungsperson
|
12.952
+7.7%
0,50
6.476 USD
|
12.952
+7.7%
|
0,50
|
6.476 USD
|
|
|
2022-04-11 |
2022-04-08 |
K
Kauf
|
Sprague John M
Chief Financial Officer
Führungsperson
|
10.000
+7.0%
0,48
4.767 USD
|
10.000
+7.0%
|
0,48
|
4.767 USD
|
|
|
2022-04-11 |
2022-04-08 |
K
Kauf
|
Giffin Brett A.
Chief Commercial Officer
Führungsperson
|
10.600
+inf%
0,49
5.183 USD
|
10.600
+inf%
|
0,49
|
5.183 USD
|
|
|
2022-04-11 |
2022-04-07 |
K
Kauf
|
Gibbs Michael Terrence
General Counsel
Führungsperson
|
10.000
+6.4%
0,49
4.900 USD
|
10.000
+6.4%
|
0,49
|
4.900 USD
|
|
|
2022-04-11 |
2022-04-07 |
K
Kauf
|
Sperzel John J III
Chairman, CEO, and President
Geschäftsführender Verwaltungsratsmitglied
|
30.000
+15.6%
0,50
15.000 USD
|
30.000
+15.6%
|
0,50
|
15.000 USD
|
|
|
2022-01-10 |
2022-01-06 |
GV
Geplanter Verkauf
|
Ahuja Aparna
Chief Medical Officer
Führungsperson
|
61.988
-36.5%
0,48
29.754 USD
|
61.988
-36.5%
|
0,48
|
29.754 USD
|
|
|
2021-03-25 |
2021-03-25 |
GV
Geplanter Verkauf
|
Gibbs Michael Terrence
General Counsel
Führungsperson
|
8.758
-10.7%
1,56
13.662 USD
|
8.758
-10.7%
|
1,56
|
13.662 USD
|
|
|
2021-03-18 |
2021-03-17 |
GV
Geplanter Verkauf
|
Barclay Alec
Chief Operations Officer
Führungsperson
|
12.494
-14.4%
1,86
23.239 USD
|
12.494
-14.4%
|
1,86
|
23.239 USD
|
|
|
2021-03-18 |
2021-03-17 |
GV
Geplanter Verkauf
|
Pare Anthony
Chief Commercial Officer
Führungsperson
|
9.620
-23.3%
1,84
17.701 USD
|
9.620
-23.3%
|
1,84
|
17.701 USD
|
|
|
2021-02-23 |
2021-02-23 |
GV
Geplanter Verkauf
|
Sprague John M
Chief Financial Officer
Führungsperson
|
5.250
-12.9%
2,04
10.710 USD
|
5.250
-12.9%
|
2,04
|
10.710 USD
|
|
|
2021-02-23 |
2021-02-23 |
GV
Geplanter Verkauf
|
Gibbs Michael Terrence
General Counsel
Führungsperson
|
7.280
-10.0%
2,06
14.997 USD
|
7.280
-10.0%
|
2,06
|
14.997 USD
|
|
|
2021-02-23 |
2021-02-23 |
GV
Geplanter Verkauf
|
Barclay Alec
Chief Operations Officer
Führungsperson
|
7.280
-10.0%
2,06
14.997 USD
|
7.280
-10.0%
|
2,06
|
14.997 USD
|
|
|
2020-03-03 |
2020-02-24 |
V
Verkauf
|
Sprague John M
Chief Financial Officer
Führungsperson
|
4.166
-15.8%
0,82
3.416 USD
|
4.166
-15.8%
|
0,82
|
3.416 USD
|
|
|
2020-02-25 |
2020-02-24 |
GV
Geplanter Verkauf
|
Lowery Thomas J.
Chief Scientific Officer
Führungsperson
|
5.808
-7.8%
0,82
4.763 USD
|
5.808
-7.8%
|
0,82
|
4.763 USD
|
|
|
2020-02-25 |
2020-02-24 |
GV
Geplanter Verkauf
|
Gibbs Michael Terrence
General Counsel
Führungsperson
|
5.808
-8.7%
0,82
4.763 USD
|
5.808
-8.7%
|
0,82
|
4.763 USD
|
|
|
2020-02-25 |
2020-02-24 |
GV
Geplanter Verkauf
|
Barclay Alec
SVP, Operations
Führungsperson
|
5.808
-11.1%
0,82
4.763 USD
|
5.808
-11.1%
|
0,82
|
4.763 USD
|
|
|
2020-02-12 |
2020-02-11 |
GV
Geplanter Verkauf
|
Lowery Thomas J.
Chief Scientific Officer
Führungsperson
|
3.200
-4.7%
0,77
2.464 USD
|
3.200
-4.7%
|
0,77
|
2.464 USD
|
|
|
2020-02-12 |
2020-02-11 |
GV
Geplanter Verkauf
|
Gibbs Michael Terrence
General Counsel
Führungsperson
|
3.200
-5.4%
0,77
2.464 USD
|
3.200
-5.4%
|
0,77
|
2.464 USD
|
|
|
2020-02-05 |
2020-02-03 |
GV
Geplanter Verkauf
|
Gibbs Michael Terrence
General Counsel
|
3.283
-5.7%
0,88
2.889 USD
|
3.283
-5.7%
|
0,88
|
2.889 USD
|
|
|
2020-02-05 |
2020-02-03 |
GV
Geplanter Verkauf
|
McDonough John
|
23.754
-4.6%
0,88
20.904 USD
|
23.754
-4.6%
|
0,88
|
20.904 USD
|
|
|
2020-02-05 |
2020-02-03 |
GV
Geplanter Verkauf
|
Lowery Thomas J.
Chief Scientific Officer
|
7.535
-10.8%
0,88
6.631 USD
|
7.535
-10.8%
|
0,88
|
6.631 USD
|
|
|
2020-01-27 |
2020-01-23 |
GV
Geplanter Verkauf
|
McDonough John
|
57.417
-10.1%
1,15
66.030 USD
|
57.417
-10.1%
|
1,15
|
66.030 USD
|
|
|
2020-01-07 |
2020-01-03 |
GV
Geplanter Verkauf
|
Elsbree David B
|
5.316
-5.5%
1,16
6.167 USD
|
5.316
-5.5%
|
1,16
|
6.167 USD
|
|
|
2019-09-13 |
2019-09-11 |
GV
Geplanter Verkauf
|
Barclay Alec
SVP, Operations
|
4.210
-9.1%
2,92
12.293 USD
|
4.210
-9.1%
|
2,92
|
12.293 USD
|
|
|
2019-06-13 |
2019-06-11 |
GV
Geplanter Verkauf
|
Cima Michael J.
|
3.240
-1.5%
1,43
4.633 USD
|
3.240
-1.5%
|
1,43
|
4.633 USD
|
|
|
2019-06-13 |
2019-06-11 |
GV
Geplanter Verkauf
|
CUMMING JOHN W
|
3.420
-12.7%
1,43
4.891 USD
|
3.420
-12.7%
|
1,43
|
4.891 USD
|
|
|
2019-06-13 |
2019-06-11 |
GV
Geplanter Verkauf
|
Lapidus Stanley
|
9.000
-14.5%
1,44
12.960 USD
|
9.000
-14.5%
|
1,44
|
12.960 USD
|
|
|
2019-06-13 |
2019-06-11 |
GV
Geplanter Verkauf
|
Elsbree David B
|
3.600
-4.2%
1,44
5.184 USD
|
3.600
-4.2%
|
1,44
|
5.184 USD
|
|
|
2019-02-12 |
2019-02-11 |
GV
Geplanter Verkauf
|
Gibbs Michael Terrence
General Counsel
Führungsperson
|
3.005
-5.0%
3,36
10.097 USD
|
3.005
-5.0%
|
3,36
|
10.097 USD
|
|
|
2019-02-12 |
2019-02-11 |
GV
Geplanter Verkauf
|
McDonough John
President & CEO
Geschäftsführender Verwaltungsratsmitglied
|
8.134
-1.8%
3,36
27.330 USD
|
8.134
-1.8%
|
3,36
|
27.330 USD
|
|
|
2019-02-12 |
2019-02-11 |
GV
Geplanter Verkauf
|
Lowery Thomas J.
Chief Scientific Officer
Führungsperson
|
3.005
-4.1%
3,36
10.097 USD
|
3.005
-4.1%
|
3,36
|
10.097 USD
|
|
|
2019-02-05 |
2019-02-01 |
V
Verkauf
|
Gibbs Michael Terrence
General Counsel
Führungsperson
|
1.820
-3.2%
3,47
6.315 USD
|
1.820
-3.2%
|
3,47
|
6.315 USD
|
|
|
2019-02-05 |
2019-02-01 |
V
Verkauf
|
Lowery Thomas J.
Chief Scientific Officer
Führungsperson
|
4.185
-5.9%
3,47
14.522 USD
|
4.185
-5.9%
|
3,47
|
14.522 USD
|
|
